EW

Edwards Lifesciences Corp. is a global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. The company is best known for its transcatheter aortic valve replacement (TAVR) systems, which provide a minimally invasive alternative to open-heart surgery for patients with aortic stenosis. Edwards also produces surgical heart valves, hemodynamic monitoring systems, and is developing technologies for treating mitral and tricuspid valve diseases. The company's products are used in hospitals worldwide and have transformed the treatment of structural heart disease.